Cargando…
LncRNA LINC01857 drives pancreatic adenocarcinoma progression via modulating miR-19a-3p/SMOC2
OBJECTIVES: Emerging evidence has demonstrated that LINC01857 exerts a pivotal function in many cancers. However, its function in Pancreatic Ductal Adenocarcinoma (PDAC) still remains unclear. This study was designed to investigate the regulatory character of LINC01857 in PDAC. METHODS: Bioinformati...
Autores principales: | Lu, Yeting, Ying, Dongjian, Tian, Yuan, Ruan, Yi, Cheng, Gong, Lv, Kaiji, Zhou, Xinhua, Han, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168480/ https://www.ncbi.nlm.nih.gov/pubmed/35662010 http://dx.doi.org/10.1016/j.clinsp.2022.100047 |
Ejemplares similares
-
LncRNA LINC01857 reduces metastasis and angiogenesis in breast cancer cells via regulating miR-2052/CENPQ axis
por: Qian, Weiwei, et al.
Publicado: (2022) -
LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis
por: Su, Jiewen, et al.
Publicado: (2022) -
Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin
por: Chen, Yun, et al.
Publicado: (2022) -
Retracted: Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1
por: Lu, Yeting, et al.
Publicado: (2022)